- Home
- JAMF vs VRDN Comparison
JAMF vs VRDN Comparison
Compare JAMF & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAMF
- VRDN
- Stock Information
- Founded
- JAMF 2002
- VRDN 2006
- Country
- JAMF United States
- VRDN United States
- Employees
- JAMF N/A
- VRDN N/A
- Industry
- JAMF Computer Software: Prepackaged Software
- VRDN Medical Specialities
- Sector
- JAMF Technology
- VRDN Health Care
- Exchange
- JAMF Nasdaq
- VRDN Nasdaq
- Market Cap
- JAMF 1.9B
- VRDN 1.6B
- IPO Year
- JAMF 2020
- VRDN N/A
- Fundamental
- Price
- JAMF $12.42
- VRDN $14.44
- Analyst Decision
- JAMF Buy
- VRDN Buy
- Analyst Count
- JAMF 9
- VRDN 12
- Target Price
- JAMF $20.78
- VRDN $36.44
- AVG Volume (30 Days)
- JAMF 812.1K
- VRDN 771.2K
- Earning Date
- JAMF 05-07-2025
- VRDN 05-07-2025
- Dividend Yield
- JAMF N/A
- VRDN N/A
- EPS Growth
- JAMF N/A
- VRDN N/A
- EPS
- JAMF N/A
- VRDN N/A
- Revenue
- JAMF $627,399,000.00
- VRDN $302,000.00
- Revenue This Year
- JAMF $11.38
- VRDN N/A
- Revenue Next Year
- JAMF $12.58
- VRDN $17,629.40
- P/E Ratio
- JAMF N/A
- VRDN N/A
- Revenue Growth
- JAMF 11.92
- VRDN N/A
- 52 Week Low
- JAMF $12.35
- VRDN $11.40
- 52 Week High
- JAMF $21.41
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- JAMF 30.56
- VRDN 38.36
- Support Level
- JAMF $12.96
- VRDN $14.03
- Resistance Level
- JAMF $13.56
- VRDN $15.91
- Average True Range (ATR)
- JAMF 0.37
- VRDN 0.70
- MACD
- JAMF -0.02
- VRDN -0.04
- Stochastic Oscillator
- JAMF 5.28
- VRDN 13.80
About JAMF Jamf Holding Corp.
Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.